Orbenin Dry Cow 500 mg Intramammary Suspension
Orbenin Dry Cow 500 mg Intramammary Suspension
Authorised
- Cloxacillin hemibenzathine
Product identification
Medicine name:
Orbenin Dry Cow 500 mg Intramammary Suspension
Active substance:
- Cloxacillin hemibenzathine
Target species:
-
Cattle
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Cloxacillin hemibenzathine1275.64/milligram(s)1.00Syringe
Pharmaceutical form:
-
Intramammary suspension
Withdrawal period by route of administration:
-
Intramammary use
-
Cattle
-
Meat and offal28day
-
Milk39day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51CF02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Ireland
Package description:
- White low density polyethylene intramammary syringe barrel containing 3 g of suspension with plunger. The closure is a white low density polyethylene push-fit combined dual nozzle and cap. Pack containing 24 syringes.
- White low density polyethylene intramammary syringe barrel containing 3 g of suspension with plunger. The closure is a white low density polyethylene push-fit combined dual nozzle and cap. Pack containing 120 syringes.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Zoetis Belgium S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Haupt Pharma Latina S.r.l.
Responsible authority:
- Health Products Regulatory Authority
Authorisation number:
- VPA10387/045/001
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 3/05/2024